MICHAEL MAITLAND was named the director of therapeutics for Inova Center for Personalized Health of Northern Virginia, and as the associate director of cancer therapeutics for the INOVA Schar Cancer Institute, both part of the Inova Health System. Maitland came to Inova from the University of Chicago, where he was the co-leader of the Cancer...
Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019).
